Associate Professor, NeurologyNew York Medical College - School of Medicine
Contact
Publications
- Balarajah S, Martinez-Gili L, Alexander JL, et. al. "A large-scale comparison of clinical outcomes to IBD therapies in White and South Asian ethnicities." EClinicalMedicine, 90(), (2025) 103644. doi: 10.1016/j.eclinm.2025.103644
- Ni SM, Li XY, Chen SJ, et. al. "Tougu Xiaotong capsules inhibit lung cancer and gefitinib-resistant cells by blocking ERBB2/PI3K-AKT-mTOR signaling and triggering ferroptosis." Phytomedicine : international journal of phytotherapy and phytopharmacology, 150(), (2025) 157741. doi: 10.1016/j.phymed.2025.157741
- Yang L, Ren A, Wang X, et. al. "Marsdenia tenacissima extract potentiates the anti-lung cancer efficacy of gefitinib through dual regulation of the Wnt pathway and ferroptosis." Journal of ethnopharmacology, 359(), (2025) 121121. doi: 10.1016/j.jep.2025.121121
- Radhakrishnan ST, Mullish BH, Olbei ML, et. al. "Deciphering the microbiome-metabolome landscape of an inflammatory bowel disease inception cohort." Gut microbes, 17(1), (2025) 2527863. doi: 10.1080/19490976.2025.2527863
- Wang YT, Liao QY, Dong YZ, et. al. "Compound kushen injection inhibits breast cancer lung metastasis through regulating MTSS1/ARPC3/F-actin." Journal of ethnopharmacology, 350(), (2025) 120054. doi: 10.1016/j.jep.2025.120054
- Zeng Z, Li J, Zheng C, et. al. "Shape memory composite membrane with widely programmable electromagnetic shielding effectiveness." Nanoscale, 17(21), (2025) 13344-13356. doi: 10.1039/d5nr01228g
- Glymenaki M, Curio S, Shrestha S, et. al. "Roux-en-Y gastric bypass-associated fecal tyramine promotes colon cancer risk via increased DNA damage, cell proliferation, and inflammation." Microbiome, 13(1), (2025) 60. doi: 10.1186/s40168-025-02049-2
